Weixu Meng

National Key Laboratory of Respiratory Diseases, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, #190 Kai Yuan Avenue, Science Park, Guangzhou 510530, China

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers10 papers

Sort

By YearBy Citation

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes

Leike Li,Weixu Meng,Melanie Horton, Daniel R DiStefano, Elizabeth A Thoryk,Jennifer M Pfaff,Qihui Wang, Georgina T Salazar,Trevor Barnes,Benjamin J Doranz,Andrew J Bett,Danilo R Casimiro

PLoS pathogens, no. 6 (2019)

WOSBibtex

Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody

Weixu Meng,Aimin Tang, Xiaohua Ye, Xun Gui, Leike Li,Xuejun Fan, Robbie D Schultz,Daniel C Freed, Sha Ha,Dai Wang,Ningyan Zhang, Tong-Ming Fu

Antimicrobial agents and chemotherapy, (2017)

WOSBibtex

Targeting human-cytomegalovirus-infected cells by redirecting T cells using an anti-CD3/anti-glycoprotein B bispecific antibody

Weixu Meng,Weixu Meng,Aimin Tang, Xiaohua Ye, Xun Gui,Leike Li,Xuejun Fan, Robbie D. Schultz,Daniel C. Freed,Sha Ha,Dai Wang,Ningyan Zhang

Antimicrobial Agents and Chemotherapy, no. 1 (2017)

Cited by2Bibtex

Anti-IL1RAP/CD3 Bispecific Antibody (BsAb) Is a Promising Novel and Effective Therapy for Acute Myeloid Leukemia (AML)

Weixu Meng, Marissa Del Real, Guowei Wei, Rochelle Hernandez, Emanuela Marcucci,Allen Lin,Tinisha Mcdonald, Dandan Zhao, Herman Wu,Nadia Carlesso,Larry W Kwak,Ling Li

Blood, (2017): 1361-1361

Bibtex

Pentameric gH complex is the primary target of neutralizing antibodies generated in cytomegalovirus vaccine immunized rabbit (VAC7P.982)

Aimin Tang,Daniel C Freed,Qi Tang,Fengsheng Li,Weixu Meng,Dai Wang,Zhiqiang An,Tongming Fu

Journal of Immunology, (2014)

Bibtex

Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases

Weixu Meng,Weiqi Pan,Anna J X Zhang,Zhengfeng Li,Guowei Wei,Liqiang Feng,Zhenyuan Dong,Chufang Li,Xiangjing Hu,Caijun Sun,Qinfang Luo,Kwok-Yung Yuen

PloS one, no. 6 (2013): e66276-e66276

Cited by19WOSSCOPUSBibtex

Visualizing influenza virus infection in living mice

Weiqi Pan,Zhenyuan Dong,Feng Li,Weixu Meng,Liqiang Feng,Xuefeng Niu,Chufang Li,Qinfang Luo,Zhengfeng Li,Caijun Sun,Ling Chen

Nature communications, no. null (2013): 2369-2369

Cited by67WOSSCOPUSNATUREBibtex

Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34

Weiqi Pan,Zhenyuan Dong,Weixu Meng,Wei Zheng,Ting Li,Chufang Li,Beiwu Zhang,Ling Chen

Human Vaccines and Immunotherapeutics, no. 2 (2012): 252-259

Cited by10WOSSCOPUSBibtex

Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein

Guowei Wei,Weixu Meng,Haijiang Guo,Weiqi Pan,Jinsong Liu,Tao Peng,Ling Chen,Chang-You Chen

PloS one, no. 12 (2011): e28309-e28309

Cited by37WOSSCOPUSBibtex

Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice

Xiangjing Hu,Weixu Meng,Zhenyuan Dong,Weiqi Pan,Caijun Sun,Ling Chen

Virus research, no. 1 (2011): 156-162

Cited by6WOSEISCOPUSBibtex

View All

Base Info Papers Patents Projects